- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
SH2D4A Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP12049a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP12049a-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
SH2D4A Antibody (N-term) - Product info | |
| Application | WB, IHC
|
| Primary Accession | Q9H788 |
| Other Accession | NP_071354.2 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 52727 Da |
SH2D4A Antibody (N-term) - Additional info | |
| Gene ID 63898 | |
| Other Names SH2D4A; SH2A; SH2 domain-containing protein 4A; Protein SH(2)A | |
| Target/Specificity This SH2D4A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 45-75 amino acids from the N-terminal region of human SH2D4A. | |
| Dilution WB~~1:100~500WB~~1:1000 IHC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions SH2D4A Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
SH2D4A Antibody (N-term) - Protein Information | |
| Name SH2D4A | |
| Synonyms PPP1R38, SH2A | |
| Function Inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation May play a role in T-cell development and function | |
| Cellular Location Cytoplasm. Note=Located at podocyte foot processes (By similarity) | |
| Tissue Location Ubiquitously expressed. Aberrantly expressed in some cancers | |
SH2D4A Antibody (N-term) - Related products
AP12049a: SH2D4A Antibody (N-term)
RI14835: SH2D4A predesign siRNA
SH2D4A Antibody (N-term) - Application data
-
SH2D4A Antibody (N-term) (Cat. #AP12049a) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the SH2D4A antibody detected the SH2D4A protein (arrow).
-
SH2D4A Antibody (N-term) (Cat. #AP12049a)immunohistochemistry analysis in formalin fixed and paraffin embedded human kidney tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SH2D4A Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
SH2D4A Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. May play a role in T-cell development and function.
REFERENCES
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Li, T., et al. BMB Rep 42(8):516-522(2009) Venkatesan, K., et al. Nat. Methods 6(1):83-90(2009) Lapinski, P.E., et al. J. Immunol. 181(3):2019-2027(2008) Sugiyama, N., et al. Mol. Cell Proteomics 6(6):1103-1109(2007)